Alfredo Garcia, MD
Cardiovascular Disease · Houston, TXNPI 1851388698
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 40 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) at 29.4% of the total. Reporting peaked in 2021 at $303 and has fallen 93.9% since, to $18 in 2025. That places this record below the midpoint for cardiovascular disease clinicians in TX, where the typical reported total is $3,258.
Across 40 payments — averaging $24.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$289
- AstraZeneca$172
- Boehringer Ingelheim$95
- Boston Scientific$54
- Chiesi USA, Inc.$51
- Irhythm Technologies, Inc.$43
- plus $281 from 11 others
What the payments were for
- Food & beverage$985100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 9 | $289 |
| AstraZeneca | 5 | $172 |
| Boehringer Ingelheim | 4 | $95 |
| Boston Scientific | 3 | $54 |
| Chiesi USA, Inc. | 3 | $51 |
| Irhythm Technologies, Inc. | 2 | $43 |
| Abbott | 2 | $41 |
| Althera Pharmaceuticals LLC | 1 | $38 |
| Novo Nordisk | 2 | $35 |
| E.r. Squibb & Sons, L.L.C. | 1 | $29 |
| Medtronic | 1 | $28 |
| Novartis | 2 | $26 |
| Astellas Pharma US Inc | 1 | $22 |
| AbbVie | 1 | $19 |
| Myocardial Solutions, Inc. | 1 | $16 |
| Agepha Pharma FZ LLC | 1 | $15 |
| Johnson & Johnson | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$125
How this compares
$985 in reported general payments places this provider in the 25th percentile of 1,515 cardiovascular disease providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 15 | $18,812 |
| Labetalol Hcl | 57 | $3,770 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 16 | $3,445 |
| Digoxin | 112 | $2,164 |
| Potassium Chloride | 73 | $1,337 |
| ClopidogrelClopidogrel Bisulfate | 71 | $1,250 |
| Diltiazem 24hr Er (La)Diltiazem Hcl | 14 | $1,125 |
| Atorvastatin Calcium | 130 | $1,072 |
| Diltiazem Hcl | 28 | $1,056 |
| Metoprolol Tartrate | 138 | $978 |
| Nitroglycerin | 13 | $905 |
| Amiodarone Hcl | 14 | $876 |
| Furosemide | 122 | $854 |
| Enalapril Maleate | 40 | $549 |
| Tamsulosin Hcl | 14 | $476 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Houston
- Biykem BozkurtHouston$606K
- Reynolds DelgadoHouston$471K
- Christie BallantyneHouston$413K
- Asif AliHouston$411K
- Sanjay ManiarHouston$263K
- Joggy GeorgeHouston$231K
- Jerry EstepHouston$226K
- Stephen LittleHouston$144K
- Akira NishikawaHouston$109K
- Andres MesaHouston$103K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.